Disappointingly, for some cancers, in particular head and neck squamous cell carcinomas and ovarian cancer, there are conflicting reports regarding the levels of SOX2 expression and patient survival [9, 49, 52, 65]. Here, SOX2 is linked to ovarian carcinoma.